US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

XILIO THERAPEUTICS, INC.

0.5412

+0.00621.16%

Volume:1.17M

Turnover:631.68K

Market Cap:36.55M

PE:-0.89

High:0.5726

Open:0.5600

Low:0.5201

Close:0.5350

52wk High:1.70

52wk Low:0.5030

Shares:67.54M

Float Shares:36.44M

Volume Ratio:2.72

T/O Rate:3.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6100

EPS(LYR):-1.0884

ROE:-908.28%

ROA:-26.26%

PB:-4.52

PE(LYR):-0.50

Loading ...

Overview Company News Filings

BRIEF-Xilio Therapeutics Announces Pricing Of Underwritten Offering

Xilio Therapeutics Prices $40 Million Pre-Funded Warrant Offering

Xilio Therapeutics Inc - Gross Proceeds From Offering Are Expected to Be Approximately $40.0 Mln

THOMSON REUTERS

Xilio Therapeutics Announces Pricing of Underwritten Offering

THOMSON REUTERS

Xilio Therapeutics Inc. Announces Date for Special Stockholders Meeting

Xilio Therapeutics Announces Leadership Transition and Pipeline Updates

BRIEF-Xilio Therapeutics Inc Appoints Sara Bonstein As Chair Of Board

Xilio Therapeutics Inc - Appoints Sara Bonstein as Chair of Board

THOMSON REUTERS

Xilio Therapeutics Raises $35.8 Million Through Series B Warrant Exercises

Press Release: Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates

Xilio Therapeutics SVP Kevin M. Brennan Reports Sale of Common Shares

Xilio Therapeutics Raises $35.8 Million From Series B Warrant Exercises

Xilio Therapeutics Inc. held special shareholder meeting

Xilio Therapeutics Q3 Net Income USD -16.287 Million

Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annua

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Applied Therapeutics (APLT) and Xilio Therapeutics (XLO)

Xilio Therapeutics' Q3 collaboration revenue rises

BRIEF-Xilio Therapeutics Q3 Net Income USD -16.287 Million

Xilio Therapeutics Inc - Anticipates Cash Runway Into Q1 2027

THOMSON REUTERS

Press Release: Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/XLO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XLO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLO\",,,,,undefined,":{"symbol":"XLO","market":"US","secType":"STK","nameCN":"XILIO THERAPEUTICS, INC.","latestPrice":0.5412,"timestamp":1770928806651,"preClose":0.535,"halted":0,"volume":1168824,"delay":0,"changeRate":0.011588785046728941,"floatShares":36436400,"shares":67540900,"eps":-0.61,"marketStatus":"Trading","change":0.0062,"latestTime":"02-12 15:40:42 EST","open":0.56,"high":0.5726,"low":0.5201,"amount":631680.0607368,"amplitude":0.098131,"askPrice":0.5446,"askSize":500,"bidPrice":0.5373,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.61,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770930000000},"marketStatusCode":2,"adr":0,"listingDate":1634875200000,"exchange":"NASDAQ","adjPreClose":0.535,"preHourTrading":{"tag":"盘前","latestPrice":0.55,"preClose":0.535,"latestTime":"09:28 EST","volume":37497,"amount":20382.0230577,"timestamp":1770906484952,"change":0.015,"changeRate":0.028037,"amplitude":0.130841},"postHourTrading":{"tag":"盘后","latestPrice":0.535,"preClose":0.535,"latestTime":"19:56 EST","volume":62,"amount":33.7798,"timestamp":1770857763000,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.720757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLO\",,,,,undefined,":{"symbol":"XLO","floatShares":36436400,"roa":"-26.26%","roe":"-908.28%","lyrEps":-1.088384,"volumeRatio":2.720757,"shares":67540900,"dividePrice":0,"high":0.5726,"amplitude":0.098131,"preClose":0.535,"low":0.5201,"week52Low":0.503,"pbRate":"-4.52","psRate":"1.15","week52High":1.7,"institutionHeld":0,"latestPrice":0.5412,"eps":-0.61,"divideRate":0,"volume":1168824,"delay":0,"ttmEps":-0.61,"open":0.56,"prevYearClose":0.6402,"prevWeekClose":0.5409,"prevMonthClose":0.5949,"prevQuarterClose":0.6402,"fiveDayClose":0.5199,"twentyDayClose":0.6458,"sixtyDayClose":0.7072},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"XLO","fiscalQuarterEnding":"2025/09","expectedEps":-0.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-0.03},{"market":"US","date":"2025-08-14","symbol":"XLO","fiscalQuarterEnding":"2025/06","expectedEps":-0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.16},{"market":"US","date":"2025-05-08","symbol":"XLO","fiscalQuarterEnding":"2025/03","expectedEps":0.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2025-03-11","symbol":"XLO","fiscalQuarterEnding":"2024/12","expectedEps":-0.22,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2024-11-07","symbol":"XLO","fiscalQuarterEnding":"2024/09","expectedEps":-0.25,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1754456400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/XLO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"XLO","date":"2026-02-11","current":-0.876066,"percent":0.735795,"low":-8.819798,"twenty":-1.002639,"median":-0.744946,"eighty":-0.577974,"high":-0.169617,"avg":-1.184815,"sd":1.431322,"marketCap":36573413},"quantilePoints":[{"date":"2021-10-22","current":-5.619943,"twenty":-5.655644,"median":-5.655644,"eighty":-5.634223,"marketCap":423962880},{"date":"2021-10-29","current":-5.897428,"twenty":-5.742879,"median":-5.655644,"eighty":-5.632588,"marketCap":444896047},{"date":"2021-11-05","current":-7.534236,"twenty":-7.275719,"median":-5.778004,"eighty":-5.653191,"marketCap":568375236},{"date":"2021-11-12","current":-7.783621,"twenty":-8.139785,"median":-6.784325,"eighty":-5.655644,"marketCap":587188588},{"date":"2021-11-19","current":-7.994369,"twenty":-8.332268,"median":-7.783621,"eighty":-5.669463,"marketCap":603087196},{"date":"2021-11-26","current":-6.993317,"twenty":-8.285904,"median":-7.699322,"eighty":-5.707754,"marketCap":527568808},{"date":"2021-12-03","current":-4.59754,"twenty":-8.14962,"median":-7.070591,"eighty":-5.652373,"marketCap":353417461},{"date":"2021-12-10","current":-3.644608,"twenty":-8.092015,"median":-6.680707,"eighty":-5.383906,"marketCap":280164654},{"date":"2021-12-17","current":-3.769058,"twenty":-8.017551,"median":-5.735855,"eighty":-4.164453,"marketCap":289731252},{"date":"2021-12-23","current":-5.689144,"twenty":-8.011931,"median":-5.689668,"eighty":-4.138852,"marketCap":437330192},{"date":"2021-12-31","current":-5.689144,"twenty":-7.994369,"median":-5.689144,"eighty":-4.156631,"marketCap":437330192},{"date":"2022-01-07","current":-5.091784,"twenty":-7.797671,"median":-5.658171,"eighty":-4.266858,"marketCap":391410521},{"date":"2022-01-14","current":-5.162898,"twenty":-7.783621,"median":-5.653587,"eighty":-4.59754,"marketCap":396877149},{"date":"2022-01-21","current":-4.842884,"twenty":-7.716182,"median":-5.64292,"eighty":-4.788126,"marketCap":372277325},{"date":"2022-01-28","current":-4.77177,"twenty":-7.567253,"median":-5.591843,"eighty":-4.822972,"marketCap":366810698},{"date":"2022-02-04","current":-3.598384,"twenty":-7.225139,"median":-5.49358,"eighty":-4.4546,"marketCap":276611346},{"date":"2022-02-11","current":-4.739768,"twenty":-7.024227,"median":-5.32737,"eighty":-4.153075,"marketCap":364350716},{"date":"2022-02-18","current":-4.82155,"twenty":-6.909018,"median":-5.17001,"eighty":-4.244813,"marketCap":370637337},{"date":"2022-02-25","current":-4.675765,"twenty":-6.763601,"median":-5.152231,"eighty":-4.222767,"marketCap":359430751},{"date":"2022-03-04","current":-3.096766,"twenty":-6.21074,"median":-5.107785,"eighty":-4.106851,"marketCap":234734857},{"date":"2022-03-11","current":-2.663652,"twenty":-5.825774,"median":-5.088228,"eighty":-3.781858,"marketCap":201904807},{"date":"2022-03-18","current":-2.77554,"twenty":-5.735355,"median":-5.013559,"eighty":-3.685854,"marketCap":210385903},{"date":"2022-03-25","current":-2.526499,"twenty":-5.698992,"median":-4.963778,"eighty":-3.539359,"marketCap":191508625},{"date":"2022-04-01","current":-2.475969,"twenty":-5.691597,"median":-4.880219,"eighty":-3.443152,"marketCap":187678452},{"date":"2022-04-08","current":-2.537327,"twenty":-5.689563,"median":-4.835772,"eighty":-3.159567,"marketCap":192329376},{"date":"2022-04-14","current":-2.180008,"twenty":-5.689144,"median":-4.77177,"eighty":-2.747387,"marketCap":165244585},{"date":"2022-04-22","current":-1.454542,"twenty":-5.689144,"median":-4.707766,"eighty":-2.648493,"marketCap":110254251},{"date":"2022-04-29","current":-1.27492,"twenty":-5.677766,"median":-4.57265,"eighty":-2.569089,"marketCap":96638949},{"date":"2022-05-06","current":-1.311037,"twenty":-5.658676,"median":-4.385974,"eighty":-2.547433,"marketCap":99376596},{"date":"2022-05-13","current":-1.14627,"twenty":-5.655644,"median":-4.188632,"eighty":-2.530108,"marketCap":92258714},{"date":"2022-05-20","current":-0.816335,"twenty":-5.654821,"median":-4.133519,"eighty":-2.502678,"marketCap":65703535},{"date":"2022-05-27","current":-1.102052,"twenty":-5.652774,"median":-3.930511,"eighty":-2.265187,"marketCap":88699772},{"date":"2022-06-03","current":-0.945588,"twenty":-5.649828,"median":-3.790392,"eighty":-1.806807,"marketCap":76106594},{"date":"2022-06-10","current":-1.017017,"twenty":-5.638325,"median":-3.710388,"eighty":-1.458346,"marketCap":81855654},{"date":"2022-06-17","current":-0.70749,"twenty":-5.619943,"median":-3.662386,"eighty":-1.354377,"marketCap":56943063},{"date":"2022-06-24","current":-0.812934,"twenty":-5.619943,"median":-3.598384,"eighty":-1.267697,"marketCap":65429770},{"date":"2022-07-01","current":-0.979602,"twenty":-5.563744,"median":-3.523713,"eighty":-1.159876,"marketCap":78844242},{"date":"2022-07-08","current":-1.17008,"twenty":-5.533214,"median":-3.456155,"eighty":-1.140148,"marketCap":94175067},{"date":"2022-07-15","current":-1.037426,"twenty":-5.49998,"median":-3.32776,"eighty":-1.085725,"marketCap":83498242},{"date":"2022-07-22","current":-1.057834,"twenty":-5.470823,"median":-3.149101,"eighty":-1.083005,"marketCap":85140831},{"date":"2022-07-29","current":-0.986405,"twenty":-5.364184,"median":-2.77554,"eighty":-1.046269,"marketCap":79391771},{"date":"2022-08-05","current":-1.102052,"twenty":-5.320424,"median":-2.696136,"eighty":-1.036746,"marketCap":88699772},{"date":"2022-08-12","current":-0.822578,"twenty":-5.273125,"median":-2.638387,"eighty":-1.029943,"marketCap":67383911},{"date":"2022-08-19","current":-0.792483,"twenty":-5.1885,"median":-2.582443,"eighty":-1.019739,"marketCap":64918646},{"date":"2022-08-26","current":-0.752358,"twenty":-5.16432,"median":-2.558983,"eighty":-0.995929,"marketCap":61631626},{"date":"2022-09-02","current":-0.692169,"twenty":-5.154364,"median":-2.548154,"eighty":-0.989126,"marketCap":56701096},{"date":"2022-09-09","current":-0.919548,"twenty":-5.147964,"median":-2.539131,"eighty":-0.97416,"marketCap":75327543},{"date":"2022-09-16","current":-1.003143,"twenty":-5.130186,"median":-2.530108,"eighty":-0.962595,"marketCap":82175502},{"date":"2022-09-23","current":-1.003143,"twenty":-5.105296,"median":-2.513866,"eighty":-0.964636,"marketCap":82175502},{"date":"2022-09-30","current":-0.973049,"twenty":-5.093206,"median":-2.475969,"eighty":-0.964636,"marketCap":79710236},{"date":"2022-10-07","current":-0.916204,"twenty":-5.08965,"median":-2.286481,"eighty":-0.962595,"marketCap":75053625},{"date":"2022-10-14","current":-0.769077,"twenty":-5.06476,"median":-1.858781,"eighty":-0.94028,"marketCap":63001218},{"date":"2022-10-21","current":-0.728951,"twenty":-5.046982,"median":-1.5525,"eighty":-0.91821,"marketCap":59714198},{"date":"2022-10-28","current":-0.782452,"twenty":-5.007158,"median":-1.454542,"eighty":-0.886404,"marketCap":64096891},{"date":"2022-11-04","current":-0.765733,"twenty":-4.979423,"median":-1.388688,"eighty":-0.850349,"marketCap":62727299},{"date":"2022-11-11","current":-0.800435,"twenty":-4.969467,"median":-1.311037,"eighty":-0.824584,"marketCap":68402762},{"date":"2022-11-18","current":-0.830646,"twenty":-4.957378,"median":-1.265891,"eighty":-0.82124,"marketCap":70984515},{"date":"2022-11-25","current":-0.849568,"twenty":-4.938888,"median":-1.206298,"eighty":-0.820572,"marketCap":72601537},{"date":"2022-12-02","current":-0.779332,"twenty":-4.887686,"median":-1.17008,"eighty":-0.816068,"marketCap":66599372},{"date":"2022-12-09","current":-0.737639,"twenty":-4.841462,"median":-1.144569,"eighty":-0.808598,"marketCap":63036442},{"date":"2022-12-16","current":-0.750468,"twenty":-4.837906,"median":-1.129263,"eighty":-0.802075,"marketCap":64132728},{"date":"2022-12-23","current":-0.753675,"twenty":-4.830083,"median":-1.115833,"eighty":-0.793821,"marketCap":64406800},{"date":"2022-12-30","current":-0.862717,"twenty":-4.811594,"median":-1.102052,"eighty":-0.792483,"marketCap":73725230},{"date":"2023-01-06","current":-0.871537,"twenty":-4.77177,"median":-1.090148,"eighty":-0.792483,"marketCap":74478927},{"date":"2023-01-13","current":-0.853096,"twenty":-4.74688,"median":-1.061235,"eighty":-0.792483,"marketCap":72903016},{"date":"2023-01-20","current":-0.894789,"twenty":-4.74119,"median":-1.053301,"eighty":-0.795158,"marketCap":76465945},{"date":"2023-01-27","current":-1.372651,"twenty":-4.688566,"median":-1.055567,"eighty":-0.795827,"marketCap":117302597},{"date":"2023-02-03","current":-1.16098,"twenty":-4.613185,"median":-1.081644,"eighty":-0.799513,"marketCap":99213879},{"date":"2023-02-10","current":-0.962138,"twenty":-4.577628,"median":-1.082826,"eighty":-0.801513,"marketCap":82221447},{"date":"2023-02-17","current":-1.148152,"twenty":-4.515758,"median":-1.061235,"eighty":-0.802368,"marketCap":98117593},{"date":"2023-02-24","current":-1.122495,"twenty":-4.501535,"median":-1.084009,"eighty":-0.802643,"marketCap":95925021},{"date":"2023-03-03","current":-0.945045,"twenty":-4.362862,"median":-1.082826,"eighty":-0.804607,"marketCap":83373763},{"date":"2023-03-10","current":-0.864219,"twenty":-4.26828,"median":-1.057834,"eighty":-0.807261,"marketCap":76243112},{"date":"2023-03-17","current":-0.913958,"twenty":-4.219922,"median":-1.04933,"eighty":-0.8088,"marketCap":80631205},{"date":"2023-03-24","current":-0.95748,"twenty":-4.169431,"median":-1.040827,"eighty":-0.809202,"marketCap":84470786},{"date":"2023-03-31","current":-0.985458,"twenty":-4.145964,"median":-1.035725,"eighty":-0.811441,"marketCap":86939088},{"date":"2023-04-06","current":-0.935719,"twenty":-4.134585,"median":-1.030623,"eighty":-0.814116,"marketCap":82550995},{"date":"2023-04-14","current":-1.032089,"twenty":-4.106851,"median":-1.030623,"eighty":-0.816068,"marketCap":91052925},{"date":"2023-04-21","current":-0.917067,"twenty":-4.017114,"median":-1.026546,"eighty":-0.816335,"marketCap":80905461},{"date":"2023-04-28","current":-0.948646,"twenty":-3.911443,"median":-1.02382,"eighty":-0.817495,"marketCap":83691451},{"date":"2023-05-05","current":-0.911322,"twenty":-3.845861,"median":-1.021746,"eighty":-0.820572,"marketCap":80398672},{"date":"2023-05-12","current":-0.980924,"twenty":-3.781858,"median":-1.017017,"eighty":-0.823915,"marketCap":87807424},{"date":"2023-05-19","current":-0.962532,"twenty":-3.746301,"median":-1.012271,"eighty":-0.827811,"marketCap":86161034},{"date":"2023-05-26","current":-0.94108,"twenty":-3.710744,"median":-1.010214,"eighty":-0.834494,"marketCap":84240763},{"date":"2023-06-02","current":-0.892033,"twenty":-3.707189,"median":-1.007219,"eighty":-0.840742,"marketCap":79850365},{"date":"2023-06-09","current":-0.921155,"twenty":-3.693676,"median":-1.004815,"eighty":-0.843978,"marketCap":82457163},{"date":"2023-06-16","current":-0.836856,"twenty":-3.65883,"median":-1.003143,"eighty":-0.837538,"marketCap":74911167},{"date":"2023-06-23","current":-0.833791,"twenty":-3.644608,"median":-0.99838,"eighty":-0.836856,"marketCap":74636767},{"date":"2023-06-30","current":-0.82766,"twenty":-3.607629,"median":-0.996609,"eighty":-0.830049,"marketCap":74087967},{"date":"2023-07-07","current":-0.78781,"twenty":-3.566382,"median":-0.993208,"eighty":-0.824593,"marketCap":70520769},{"date":"2023-07-14","current":-0.815398,"twenty":-3.536514,"median":-0.99316,"eighty":-0.822592,"marketCap":72990368},{"date":"2023-07-21","current":-0.842987,"twenty":-3.522291,"median":-0.989806,"eighty":-0.82124,"marketCap":75459967},{"date":"2023-07-28","current":-0.849118,"twenty":-3.486734,"median":-0.985931,"eighty":-0.822592,"marketCap":76008766},{"date":"2023-08-04","current":-0.842987,"twenty":-3.454022,"median":-0.985458,"eighty":-0.822602,"marketCap":75459967},{"date":"2023-08-11","current":-0.873641,"twenty":-3.441984,"median":-0.980924,"eighty":-0.823797,"marketCap":78203965},{"date":"2023-08-18","current":-0.878604,"twenty":-3.372515,"median":-0.979241,"eighty":-0.82539,"marketCap":74028579},{"date":"2023-08-25","current":-0.940627,"twenty":-3.299607,"median":-0.975457,"eighty":-0.826964,"marketCap":79254417},{"date":"2023-09-01","current":-0.937361,"twenty":-3.233197,"median":-0.973023,"eighty":-0.82766,"marketCap":78979228},{"date":"2023-09-08","current":-0.885104,"twenty":-3.159567,"median":-0.971728,"eighty":-0.82766,"marketCap":74576205},{"date":"2023-09-15","current":-0.829581,"twenty":-2.981269,"median":-0.970062,"eighty":-0.826617,"marketCap":69897993},{"date":"2023-09-22","current":-0.76426,"twenty":-2.79503,"median":-0.966806,"eighty":-0.822588,"marketCap":64394214},{"date":"2023-09-29","current":-0.70547,"twenty":-2.766156,"median":-0.965603,"eighty":-0.816906,"marketCap":59440813},{"date":"2023-10-06","current":-0.646681,"twenty":-2.727897,"median":-0.962595,"eighty":-0.815979,"marketCap":54487412},{"date":"2023-10-13","current":-0.604222,"twenty":-2.71346,"median":-0.962532,"eighty":-0.812453,"marketCap":50909955},{"date":"2023-10-20","current":-0.636883,"twenty":-2.666539,"median":-0.960045,"eighty":-0.808397,"marketCap":53661845},{"date":"2023-10-27","current":-0.679342,"twenty":-2.665096,"median":-0.95957,"eighty":-0.806065,"marketCap":57239301},{"date":"2023-11-03","current":-0.816517,"twenty":-2.648493,"median":-0.95748,"eighty":-0.802222,"marketCap":68797237},{"date":"2023-11-10","current":-0.522571,"twenty":-2.614566,"median":-0.947902,"eighty":-0.798373,"marketCap":44030232},{"date":"2023-11-17","current":-0.442347,"twenty":-2.594354,"median":-0.946599,"eighty":-0.792483,"marketCap":35925248},{"date":"2023-11-24","current":-0.401672,"twenty":-2.584248,"median":-0.945588,"eighty":-0.790684,"marketCap":32621777},{"date":"2023-12-01","current":-0.305101,"twenty":-2.570532,"median":-0.942446,"eighty":-0.788267,"marketCap":24778786},{"date":"2023-12-08","current":-0.311846,"twenty":-2.563314,"median":-0.941074,"eighty":-0.783066,"marketCap":25326611},{"date":"2023-12-15","current":-0.247443,"twenty":-2.556095,"median":-0.940627,"eighty":-0.780271,"marketCap":20096115},{"date":"2023-12-22","current":-0.180091,"twenty":-2.551764,"median":-0.938014,"eighty":-0.774301,"marketCap":14626118},{"date":"2023-12-29","current":-0.193209,"twenty":-2.551764,"median":-0.937361,"eighty":-0.770792,"marketCap":15691487},{"date":"2024-01-05","current":-0.245647,"twenty":-2.547433,"median":-0.936267,"eighty":-0.769457,"marketCap":19950212},{"date":"2024-01-12","current":-0.275645,"twenty":-2.54238,"median":-0.935334,"eighty":-0.766195,"marketCap":22386522},{"date":"2024-01-19","current":-0.233071,"twenty":-2.539492,"median":-0.934949,"eighty":-0.764849,"marketCap":18928889},{"date":"2024-01-26","current":-0.216937,"twenty":-2.534439,"median":-0.93261,"eighty":-0.754249,"marketCap":17618512},{"date":"2024-02-02","current":-0.227106,"twenty":-2.530108,"median":-0.92518,"eighty":-0.752358,"marketCap":18444380},{"date":"2024-02-09","current":-0.203378,"twenty":-2.528664,"median":-0.923284,"eighty":-0.751224,"marketCap":16517355},{"date":"2024-02-16","current":-0.199107,"twenty":-2.525055,"median":-0.920389,"eighty":-0.749014,"marketCap":16170491},{"date":"2024-02-23","current":-0.18643,"twenty":-2.519281,"median":-0.919085,"eighty":-0.746197,"marketCap":15140909},{"date":"2024-03-01","current":-0.240325,"twenty":-2.504121,"median":-0.917067,"eighty":-0.739651,"marketCap":19518008},{"date":"2024-03-08","current":-0.270832,"twenty":-2.496181,"median":-0.915351,"eighty":-0.735638,"marketCap":21995611},{"date":"2024-03-15","current":-0.219174,"twenty":-2.466585,"median":-0.913491,"eighty":-0.731225,"marketCap":17800203},{"date":"2024-03-22","current":-0.238122,"twenty":-2.421829,"median":-0.911599,"eighty":-0.715205,"marketCap":19339070},{"date":"2024-03-28","current":-0.216598,"twenty":-2.392955,"median":-0.911029,"eighty":-0.70547,"marketCap":17590983},{"date":"2024-04-05","current":-0.545745,"twenty":-2.180008,"median":-0.910426,"eighty":-0.68914,"marketCap":41697098},{"date":"2024-04-12","current":-0.613532,"twenty":-2.057292,"median":-0.907037,"eighty":-0.679342,"marketCap":46876301},{"date":"2024-04-19","current":-0.577442,"twenty":-1.858781,"median":-0.904632,"eighty":-0.663875,"marketCap":44118872},{"date":"2024-04-26","current":-0.455638,"twenty":-1.793814,"median":-0.901286,"eighty":-0.653213,"marketCap":34812547},{"date":"2024-05-03","current":-0.507198,"twenty":-1.570039,"median":-0.897996,"eighty":-0.636883,"marketCap":38751930},{"date":"2024-05-10","current":-0.608637,"twenty":-1.534961,"median":-0.892115,"eighty":-0.623819,"marketCap":46502316},{"date":"2024-05-17","current":-0.561705,"twenty":-1.473562,"median":-0.887764,"eighty":-0.608637,"marketCap":39859128},{"date":"2024-05-24","current":-0.556504,"twenty":-1.454542,"median":-0.885503,"eighty":-0.604222,"marketCap":39490062},{"date":"2024-05-31","current":-0.483742,"twenty":-1.448767,"median":-0.881558,"eighty":-0.597071,"marketCap":34326828},{"date":"2024-06-07","current":-0.53057,"twenty":-1.404749,"median":-0.876706,"eighty":-0.586439,"marketCap":37649763},{"date":"2024-06-14","current":-0.546175,"twenty":-1.387604,"median":-0.876079,"eighty":-0.580482,"marketCap":38757109},{"date":"2024-06-21","current":-0.496031,"twenty":-1.379022,"median":-0.873673,"eighty":-0.570621,"marketCap":35198837},{"date":"2024-06-28","current":-0.488956,"twenty":-1.374775,"median":-0.873641,"eighty":-0.569679,"marketCap":34696841},{"date":"2024-07-05","current":-0.448904,"twenty":-1.357353,"median":-0.873641,"eighty":-0.561773,"marketCap":31854652},{"date":"2024-07-12","current":-0.520114,"twenty":-1.333588,"median":-0.87282,"eighty":-0.555857,"marketCap":36907841},{"date":"2024-07-15","current":-0.53057,"twenty":-1.329066,"median":-0.872339,"eighty":-0.554184,"marketCap":37649763},{"date":"2024-08-02","current":-0.494158,"twenty":-1.324544,"median":-0.872339,"eighty":-0.551376,"marketCap":35065956},{"date":"2024-08-09","current":-0.483847,"twenty":-1.311037,"median":-0.871537,"eighty":-0.546175,"marketCap":31707006},{"date":"2024-08-16","current":-0.556692,"twenty":-1.27492,"median":-0.868973,"eighty":-0.546175,"marketCap":36480567},{"date":"2024-08-23","current":-0.597874,"twenty":-1.27323,"median":-0.865924,"eighty":-0.546175,"marketCap":39179250},{"date":"2024-08-30","current":-0.538985,"twenty":-1.267697,"median":-0.863468,"eighty":-0.546175,"marketCap":35320221},{"date":"2024-09-06","current":-0.518595,"twenty":-1.264807,"median":-0.862048,"eighty":-0.54616,"marketCap":33984066},{"date":"2024-09-13","current":-0.549985,"twenty":-1.263703,"median":-0.858314,"eighty":-0.545667,"marketCap":36041042},{"date":"2024-09-20","current":-0.524699,"twenty":-1.232207,"median":-0.857152,"eighty":-0.544779,"marketCap":34384033},{"date":"2024-09-27","current":-0.504376,"twenty":-1.201879,"median":-0.854893,"eighty":-0.540606,"marketCap":33052273},{"date":"2024-10-04","current":-0.486602,"twenty":-1.189844,"median":-0.850349,"eighty":-0.531977,"marketCap":31887532},{"date":"2024-10-11","current":-0.528522,"twenty":-1.186983,"median":-0.849328,"eighty":-0.53057,"marketCap":34634562},{"date":"2024-10-18","current":-0.529863,"twenty":-1.186643,"median":-0.84452,"eighty":-0.530429,"marketCap":34722467},{"date":"2024-10-25","current":-0.62108,"twenty":-1.173809,"median":-0.842987,"eighty":-0.530429,"marketCap":40700006},{"date":"2024-10-31","current":-0.918877,"twenty":-1.170289,"median":-0.84264,"eighty":-0.53057,"marketCap":60214912},{"date":"2024-11-08","current":-0.727841,"twenty":-1.17008,"median":-0.842987,"eighty":-0.53057,"marketCap":45710590},{"date":"2024-11-15","current":-0.669964,"twenty":-1.168468,"median":-0.840267,"eighty":-0.53057,"marketCap":42075719},{"date":"2024-11-22","current":-0.643941,"twenty":-1.163546,"median":-0.839921,"eighty":-0.531625,"marketCap":40441428},{"date":"2024-11-29","current":-0.76293,"twenty":-1.160538,"median":-0.835323,"eighty":-0.532657,"marketCap":47914300},{"date":"2024-12-06","current":-0.734933,"twenty":-1.159035,"median":-0.830725,"eighty":-0.534491,"marketCap":46155977},{"date":"2024-12-13","current":-0.720934,"twenty":-1.15649,"median":-0.82862,"eighty":-0.53653,"marketCap":45276816},{"date":"2024-12-20","current":-0.65654,"twenty":-1.152,"median":-0.82766,"eighty":-0.53657,"marketCap":41232673},{"date":"2024-12-27","current":-0.682437,"twenty":-1.147776,"median":-0.825921,"eighty":-0.53657,"marketCap":42859122},{"date":"2025-01-03","current":-0.748931,"twenty":-1.14627,"median":-0.822602,"eighty":-0.53657,"marketCap":47035139},{"date":"2025-01-10","current":-0.783928,"twenty":-1.145209,"median":-0.822578,"eighty":-0.537107,"marketCap":49233042},{"date":"2025-01-17","current":-0.797927,"twenty":-1.143284,"median":-0.817491,"eighty":-0.538636,"marketCap":50112204},{"date":"2025-01-24","current":-0.580737,"twenty":-1.142869,"median":-0.816517,"eighty":-0.540201,"marketCap":36472013},{"date":"2025-01-31","current":-0.486385,"twenty":-1.140266,"median":-0.816335,"eighty":-0.53657,"marketCap":30546465},{"date":"2025-02-07","current":-0.482956,"twenty":-1.13297,"median":-0.815659,"eighty":-0.532822,"marketCap":30331071},{"date":"2025-02-14","current":-0.902917,"twenty":-1.125202,"median":-0.815429,"eighty":-0.53057,"marketCap":56705915},{"date":"2025-02-21","current":-0.771637,"twenty":-1.122495,"median":-0.815398,"eighty":-0.531274,"marketCap":48461135},{"date":"2025-02-28","current":-0.649413,"twenty":-1.121121,"median":-0.810785,"eighty":-0.532657,"marketCap":40785074},{"date":"2025-03-07","current":-0.678968,"twenty":-1.117838,"median":-0.809202,"eighty":-0.534491,"marketCap":42641227},{"date":"2025-03-14","current":-0.710276,"twenty":-1.115867,"median":-0.80603,"eighty":-0.53653,"marketCap":41367199},{"date":"2025-03-21","current":-0.696942,"twenty":-1.110216,"median":-0.804926,"eighty":-0.53657,"marketCap":40590594},{"date":"2025-03-28","current":-0.648849,"twenty":-1.102052,"median":-0.802148,"eighty":-0.53657,"marketCap":37789636},{"date":"2025-04-04","current":-0.622447,"twenty":-1.09797,"median":-0.800186,"eighty":-0.536838,"marketCap":36251956},{"date":"2025-04-11","current":-0.588045,"twenty":-1.090488,"median":-0.797927,"eighty":-0.537939,"marketCap":34248313},{"date":"2025-04-17","current":-0.67374,"twenty":-1.087559,"median":-0.796877,"eighty":-0.53939,"marketCap":39239300},{"date":"2025-04-25","current":-0.744946,"twenty":-1.083536,"median":-0.792483,"eighty":-0.541079,"marketCap":43386374},{"date":"2025-05-02","current":-0.671162,"twenty":-1.080126,"median":-0.792322,"eighty":-0.54163,"marketCap":39089156},{"date":"2025-05-09","current":-0.686464,"twenty":-1.071492,"median":-0.790557,"eighty":-0.542848,"marketCap":37277076},{"date":"2025-05-16","current":-0.762738,"twenty":-1.071492,"median":-0.789848,"eighty":-0.543277,"marketCap":41418973},{"date":"2025-05-23","current":-0.855362,"twenty":-1.060555,"median":-0.79216,"eighty":-0.543653,"marketCap":46448698},{"date":"2025-05-30","current":-0.919156,"twenty":-1.057834,"median":-0.792483,"eighty":-0.545155,"marketCap":49912932},{"date":"2025-06-06","current":-0.646814,"twenty":-1.056958,"median":-0.792322,"eighty":-0.545357,"marketCap":35123915},{"date":"2025-06-13","current":-0.651868,"twenty":-1.053301,"median":-0.790557,"eighty":-0.545745,"marketCap":35398361},{"date":"2025-06-20","current":-0.629935,"twenty":-1.051485,"median":-0.788953,"eighty":-0.546031,"marketCap":34207369},{"date":"2025-06-27","current":-0.647958,"twenty":-1.04831,"median":-0.786803,"eighty":-0.54616,"marketCap":35186054},{"date":"2025-07-03","current":-0.665599,"twenty":-1.044442,"median":-0.783892,"eighty":-0.546175,"marketCap":36144026},{"date":"2025-07-11","current":-0.709368,"twenty":-1.041423,"median":-0.782539,"eighty":-0.546175,"marketCap":38520832},{"date":"2025-07-18","current":-0.691346,"twenty":-1.040286,"median":-0.782066,"eighty":-0.546328,"marketCap":37542147},{"date":"2025-07-25","current":-0.658066,"twenty":-1.038426,"median":-0.77892,"eighty":-0.547154,"marketCap":35734946},{"date":"2025-08-01","current":-0.618683,"twenty":-1.036513,"median":-0.775821,"eighty":-0.549045,"marketCap":33596338},{"date":"2025-08-08","current":-0.624977,"twenty":-1.034776,"median":-0.772918,"eighty":-0.549985,"marketCap":33938101},{"date":"2025-08-15","current":-0.670671,"twenty":-1.032863,"median":-0.770792,"eighty":-0.55082,"marketCap":36419472},{"date":"2025-08-22","current":-0.617635,"twenty":-1.031209,"median":-0.769929,"eighty":-0.551376,"marketCap":34724699},{"date":"2025-08-29","current":-0.636533,"twenty":-1.030623,"median":-0.769394,"eighty":-0.551376,"marketCap":35787171},{"date":"2025-09-05","current":-0.661884,"twenty":-1.029262,"median":-0.768301,"eighty":-0.552107,"marketCap":37212439},{"date":"2025-09-12","current":-0.67267,"twenty":-1.026894,"median":-0.765733,"eighty":-0.553877,"marketCap":37818825},{"date":"2025-09-19","current":-0.703736,"twenty":-1.026191,"median":-0.764997,"eighty":-0.555533,"marketCap":39565426},{"date":"2025-09-26","current":-0.699864,"twenty":-1.025051,"median":-0.763296,"eighty":-0.556579,"marketCap":39347749},{"date":"2025-10-03","current":-0.737475,"twenty":-1.02382,"median":-0.763296,"eighty":-0.557899,"marketCap":41462328},{"date":"2025-10-10","current":-0.772782,"twenty":-1.023522,"median":-0.763296,"eighty":-0.560508,"marketCap":43447336},{"date":"2025-10-17","current":-0.698758,"twenty":-1.022012,"median":-0.76293,"eighty":-0.561705,"marketCap":39285555},{"date":"2025-10-24","current":-0.712693,"twenty":-1.020384,"median":-0.762738,"eighty":-0.561728,"marketCap":40069009},{"date":"2025-10-31","current":-0.74083,"twenty":-1.020145,"median":-0.759092,"eighty":-0.56177,"marketCap":41650949},{"date":"2025-11-07","current":-0.766643,"twenty":-1.018727,"median":-0.758032,"eighty":-0.56383,"marketCap":43102202},{"date":"2025-11-14","current":-0.646705,"twenty":-1.01548,"median":-0.755931,"eighty":-0.567511,"marketCap":36359060},{"date":"2025-11-21","current":-0.673208,"twenty":-1.013175,"median":-0.755835,"eighty":-0.569049,"marketCap":39375246},{"date":"2025-11-28","current":-0.68003,"twenty":-1.012814,"median":-0.754068,"eighty":-0.569994,"marketCap":39774248},{"date":"2025-12-05","current":-0.665129,"twenty":-1.01116,"median":-0.753333,"eighty":-0.570308,"marketCap":38902743},{"date":"2025-12-12","current":-0.637573,"twenty":-1.010305,"median":-0.752358,"eighty":-0.571566,"marketCap":37290982},{"date":"2025-12-19","current":-0.583447,"twenty":-1.009615,"median":-0.752358,"eighty":-0.572048,"marketCap":34125213},{"date":"2025-12-26","current":-0.59718,"twenty":-1.007219,"median":-0.751088,"eighty":-0.57391,"marketCap":34928468},{"date":"2026-01-02","current":-0.57465,"twenty":-1.007219,"median":-0.749014,"eighty":-0.573996,"marketCap":33610709},{"date":"2026-01-09","current":-0.649421,"twenty":-1.006894,"median":-0.749014,"eighty":-0.574523,"marketCap":37983987},{"date":"2026-01-16","current":-0.739164,"twenty":-1.006552,"median":-0.749014,"eighty":-0.575254,"marketCap":43232949},{"date":"2026-01-23","current":-0.712951,"twenty":-1.004481,"median":-0.748619,"eighty":-0.57625,"marketCap":41699770},{"date":"2026-01-30","current":-0.70429,"twenty":-1.003143,"median":-0.745746,"eighty":-0.57719,"marketCap":41193213},{"date":"2026-02-06","current":-0.600361,"twenty":-1.003143,"median":-0.745551,"eighty":-0.577442,"marketCap":35114529},{"date":"2026-02-11","current":-0.625304,"twenty":-1.002639,"median":-0.744946,"eighty":-0.577974,"marketCap":36573413}],"updateTime":1770925898995},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XLO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610821991","title":"BRIEF-Xilio Therapeutics Announces Pricing Of Underwritten Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2610821991","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610821991?lang=en_us&edition=fundamental","pubTime":"2026-02-12 10:45","pubTimestamp":1770864348,"startTime":"0","endTime":"0","summary":"BRIEF-Xilio Therapeutics Announces Pricing Of Underwritten OfferingFeb 12 (Reuters) - Xilio Therapeutics Inc XLO.O:XILIO THERAPEUTICS ANNOUNCES PRICING OF UNDERWRITTEN OFFERINGXILIO THERAPEUTICS INC -","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nTUA9SZH86:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2610409999","title":"Xilio Therapeutics Prices $40 Million Pre-Funded Warrant Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2610409999","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610409999?lang=en_us&edition=fundamental","pubTime":"2026-02-12 10:36","pubTimestamp":1770863766,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc. has announced the pricing of an underwritten offering of pre-funded warrants to purchase 74,780,300 shares of common stock at $0.5349 per warrant. Each warrant is immediately exercisable for one share of common stock at an exercise price of $0.0001 per share. The offering is expected to raise approximately $40 million in gross proceeds, which will be used to advance the development of Xilio’s product candidates and for general corporate purposes. The financing was led by Coastlands Capital, with participation from Gilead Sciences, OrbiMed, Perceptive Advisors, and other investors. Leerink Partners is serving as the sole bookrunner for the offering.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDL1LzcZ4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1430594728.SGD","LU1778281490.HKD","SG9999015945.SGD","BK4578","LU1066051498.USD","LU2468319806.SGD","BK4139","LU1571399168.USD","BK4588","IE0002270589.USD","LU0889565916.HKD","IE00B19Z3581.USD","LU1674673691.USD","BK4566","LU0234570918.USD","LU2324357040.USD","LU0289739699.SGD","SG9999015986.USD","SG9999015978.USD","BK4585","LU0109394709.USD","LU0320765992.SGD","LU2087621335.USD","LU0823416689.USD","IE00B3T34201.USD","IE00BSNM7G36.USD","LU1585245621.USD","LU0882574055.USD","LU1839511570.USD","LU2089984988.USD","IE00B7SZLL34.SGD","BK4568","SG9999015952.SGD","IE00B19Z3B42.SGD","BK4583","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","MNSH","BK4207","LU0058720904.USD","XLO","GILD","LU1066053197.SGD","BK4550","LU1674673428.USD","LU0114720955.EUR"],"gpt_icon":0},{"id":"2610699941","title":"Xilio Therapeutics Inc - Gross Proceeds From Offering Are Expected to Be Approximately $40.0 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2610699941","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610699941?lang=en_us&edition=fundamental","pubTime":"2026-02-12 10:34","pubTimestamp":1770863653,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nTUA9SZH86:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2610415999","title":"Xilio Therapeutics Announces Pricing of Underwritten Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2610415999","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610415999?lang=en_us&edition=fundamental","pubTime":"2026-02-12 10:34","pubTimestamp":1770863653,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nTUA9SZH86:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2604991964","title":"Xilio Therapeutics Inc. Announces Date for Special Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2604991964","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604991964?lang=en_us&edition=fundamental","pubTime":"2026-01-17 05:06","pubTimestamp":1768597589,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc. has announced that a special meeting of stockholders will be held online. During the meeting, stockholders will consider and vote on proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of the board of directors or by a stockholder of record on the record date for the meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nNDL3H0927:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2601367292","title":"Xilio Therapeutics Announces Leadership Transition and Pipeline Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2601367292","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601367292?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:55","pubTimestamp":1767880537,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics ( ($XLO) ) has provided an announcement. On January 8, 2026, Xilio Therapeutics reported a series of corporate and pipeline upda...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xilio-therapeutics-announces-leadership-transition-and-pipeline-updates?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xilio-therapeutics-announces-leadership-transition-and-pipeline-updates?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","XLO","BK4139","BK4539"],"gpt_icon":0},{"id":"2601367599","title":"BRIEF-Xilio Therapeutics Inc  Appoints Sara Bonstein As Chair Of Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2601367599","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601367599?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:52","pubTimestamp":1767880321,"startTime":"0","endTime":"0","summary":"BRIEF-Xilio Therapeutics Inc  Appoints Sara Bonstein As Chair Of BoardJan 8 (Reuters) - Xilio Therapeutics Inc XLO.O:XILIO THERAPEUTICS INC - APPOINTS SARA BONSTEIN AS CHAIR OF BOARDSource text: ID:nGNXMHLsmFurther company coverage: XLO.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y9112:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2601186362","title":"Xilio Therapeutics Inc - Appoints Sara Bonstein as Chair of Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2601186362","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601186362?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:32","pubTimestamp":1767879172,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y9112:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2601362991","title":"Xilio Therapeutics Raises $35.8 Million Through Series B Warrant Exercises","url":"https://stock-news.laohu8.com/highlight/detail?id=2601362991","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601362991?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:30","pubTimestamp":1767879013,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc. announced the receipt of $35.8 million in gross proceeds from the exercise of Series B warrants. The exercise included full participation by Coastlands Capital, Frazier Life Sciences, and Gilead Sciences, Inc. The Series B warrants were originally issued in connection with a follow-on public offering in June 2025. The proceeds are expected to extend Xilio's anticipated cash runway into the second quarter of 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on January 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL7ZgZm1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SG9999014039.USD","IE00BKPKM429.USD","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","SG9999014005.SGD","XLO","BK4139","LU2095319765.USD","NDAQ","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU0314104364.USD","LU2210150020.SGD","SG9999014021.USD","BK4112","BK4588"],"gpt_icon":0},{"id":"2601362921","title":"Press Release: Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2601362921","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601362921?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:30","pubTimestamp":1767879000,"startTime":"0","endTime":"0","summary":"Received $35.8 million in gross proceeds from Series B warrant exercises, including full exercise by Coastlands Capital, Frazier Life Sciences and Gilead Sciences, Inc., and extended anticipated cash runway into second quarter of 2027. Achieved development milestone for masked antibody-based program under AbbVie agreement. Nominated development candidate for wholly-owned masked T cell engager program targeting CLDN18.2. Appoints Sara Bonstein as chair of board of directors. WALTHAM, Mass., Jan. 08, 2026  -- Xilio Therapeutics, Inc. , a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today highlighted upcoming milestones and recent corporate updates.In January 2026, Xilio announced the receipt of $35.8 million in gross proceeds from the exercise of Series B warrants, before deducting underwriting discounts and commissions and any offering expenses, including the full exercise of Series B warrants held by Coa","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4539","XLO","BK4007","BK4139","IND"],"gpt_icon":0},{"id":"2601858913","title":"Xilio Therapeutics SVP Kevin M. Brennan Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2601858913","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601858913?lang=en_us&edition=fundamental","pubTime":"2026-01-06 06:26","pubTimestamp":1767652014,"startTime":"0","endTime":"0","summary":"Kevin M. Brennan, SVP, Finance and Accounting, reported a disposal of common shares of Xilio Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDLbTRZC3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Xilio Therapeutics SVP Kevin M. Brennan Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2601884361","title":"Xilio Therapeutics Raises $35.8 Million From Series B Warrant Exercises","url":"https://stock-news.laohu8.com/highlight/detail?id=2601884361","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601884361?lang=en_us&edition=fundamental","pubTime":"2026-01-05 21:31","pubTimestamp":1767619881,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc. announced that, following a June 2025 public offering, 48,207,815 Series B warrants were exercised through December 31, 2025, resulting in the issuance of 8,202,815 shares of common stock and 40,005,000 prefunded warrants. The company raised $35.8 million in gross proceeds from these exercises. Additionally, 66,676,000 Series C warrants were issued in connection with the offering, with 48,207,815 Series C warrants remaining outstanding. If all outstanding Series C warrants are exercised at their current price of $0.75 per warrant, Xilio could receive up to $36.2 million in additional gross proceeds by the end of 2026. As of January 2, 2026, Xilio had 67,540,930 shares of common stock outstanding.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financia","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDLbhrLsX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2586409363","title":"Xilio Therapeutics Inc. held special shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2586409363","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586409363?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:06","pubTimestamp":1764104779,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics Inc. held a special meeting of stockholders on November 21, 2025. Stockholders approved a one-time repricing of certain outstanding employee stock options. Approval was also given for the 2025 Stock Incentive Plan. In addition, stockholders approved the proposal to allow adjournment of the special meeting if necessary.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xilio Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 25, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL6rnmWy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2584492287","title":"Xilio Therapeutics Q3 Net Income USD -16.287 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584492287","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584492287?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:37","pubTimestamp":1763573856,"startTime":"0","endTime":"0","summary":"Nov 13 (Reuters) - Xilio Therapeutics Q3 income from operations USD -1.929 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 13-NOV-202512:00:00.157 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD9grDsN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2584929288","title":"Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annua","url":"https://stock-news.laohu8.com/highlight/detail?id=2584929288","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584929288?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:06","pubTimestamp":1763571986,"startTime":"0","endTime":"0","summary":"Nov 7 (Reuters) - Xilio Therapeutics Inc ::*XILIO THERAPEUTICS ANNOUNCES LATE-BREAKING PHASE 2 DATA FOR VILASTOBART IN PATIENTS WITH MSS MCRC AND HIGH PLASMA TUMOR MUTATIONAL BURDEN AT SOCIETY FOR IMM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD2RDD4b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2583254807","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Applied Therapeutics (APLT) and Xilio Therapeutics (XLO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583254807","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583254807?lang=en_us&edition=fundamental","pubTime":"2025-11-14 06:50","pubTimestamp":1763074211,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Applied Therapeutics (APLT – Research Report) and Xilio Therapeut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-applied-therapeutics-aplt-and-xilio-therapeutics-xlo-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-applied-therapeutics-aplt-and-xilio-therapeutics-xlo-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BK4581","BK4585","APLT","HCSG","XLO","LABU","LU0029874061.USD","LU0128526141.USD","BK4588","XBI","LU0109394709.USD","BK4137","BK4139","LU0320765992.SGD","XLV"],"gpt_icon":0},{"id":"2583608525","title":"Xilio Therapeutics' Q3 collaboration revenue rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2583608525","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583608525?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:42","pubTimestamp":1763037734,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics' Q3 collaboration revenue risesOverviewXilio Q3 collaboration revenue rises to $19.1 mln from $2.3 mln year-over-yearNet loss for Q3 widens to $16.3 mln from $14.0 mln year-over-yea","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL1N3WP0HR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2583604567","title":"BRIEF-Xilio Therapeutics Q3 Net Income USD -16.287 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583604567","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583604567?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:30","pubTimestamp":1763037046,"startTime":"0","endTime":"0","summary":"BRIEF-Xilio Therapeutics Q3 Net Income USD -16.287 Million\n\n\nNov 13 (Reuters) - Xilio Therapeutics Q3 income from operations USD -1.929 million.\n\nQ3 operating expenses USD 20.995 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX15AA63:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLO","BK4139"],"gpt_icon":0},{"id":"2583671415","title":"Xilio Therapeutics Inc - Anticipates Cash Runway Into Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2583671415","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583671415?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:30","pubTimestamp":1763037001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX15AA63:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XLO"],"gpt_icon":0},{"id":"2583679215","title":"Press Release: Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583679215","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583679215?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:30","pubTimestamp":1763037000,"startTime":"0","endTime":"0","summary":"Reported late-breaking Phase 2 data at SITC for vilastobart demonstrating a 40% ORR in heavily pretreated patients with MSS mCRC without liver metastases and high plasma tumor mutational burden. Presented Phase 1 data at SITC for efarindodekin alfa showing promising monotherapy anti-tumor activity and generally well-tolerated safety profile in patients with advanced solid tumors. Announced new preclinical data at SITC for masked T cell engager programs supporting best-in-class potential and showing efficient masking, potent anti-tumor activity and broad therapeutic index. Anticipate cash runway into the first quarter of 2027. WALTHAM, Mass., Nov. 13, 2025  -- Xilio Therapeutics, Inc. , a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced pipeline progress and business updates and reported financial results for the third quarter ended September 30, 2025.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4232","ORR","BK4113","L","BK4080","TMB","XLO","BK4107","BK4588","LU0053666078.USD","BK4007","LU0210528500.USD","BK4539","LU2487616109.SGD","MSS","BK4022","LENZ","SITC","BK4231","BK4585","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}]}}